These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 2109376)
1. Delayed treatment with a t-PA analogue and streptokinase in a rabbit embolic stroke model. Phillips DA; Fisher M; Davis MA; Smith TW; Pang RH Stroke; 1990 Apr; 21(4):602-5. PubMed ID: 2109376 [TBL] [Abstract][Full Text] [Related]
2. The effects of a new tissue plasminogen activator analogue, Fb-Fb-CF, on cerebral reperfusion in a rabbit embolic stroke model. Phillips DA; Fisher M; Smith TW; Davis MA; Pang RH Ann Neurol; 1989 Mar; 25(3):281-5. PubMed ID: 2499244 [TBL] [Abstract][Full Text] [Related]
3. Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected]. Lyden PD; Madden KP; Clark WM; Sasse KC; Zivin JA Stroke; 1990 Nov; 21(11):1589-93. PubMed ID: 2122552 [TBL] [Abstract][Full Text] [Related]
4. Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected]. Benes V; Zabramski JM; Boston M; Puca A; Spetzler RF Stroke; 1990 Nov; 21(11):1594-9. PubMed ID: 2122553 [TBL] [Abstract][Full Text] [Related]
5. Fibrinolytic drugs prevent pericardial adhesions in the rabbit. Wiseman DM; Kamp L; Linsky CB; Jochen RF; Pang RH; Scholz PM J Surg Res; 1992 Oct; 53(4):362-8. PubMed ID: 1405617 [TBL] [Abstract][Full Text] [Related]
6. A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding. Thomas GR; Thibodeaux H; Errett CJ; Badillo JM; Keyt BA; Refino CJ; Zivin JA; Bennett WF Stroke; 1994 Oct; 25(10):2072-8; discussion 2078-9. PubMed ID: 8091454 [TBL] [Abstract][Full Text] [Related]
7. [Thrombolytic therapy in ischemic infarct]. Willig V; Steiner T; Hacke W Wien Klin Wochenschr; 1997 Oct; 109(20):795-803. PubMed ID: 9454430 [TBL] [Abstract][Full Text] [Related]
14. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. del Zoppo GJ; Poeck K; Pessin MS; Wolpert SM; Furlan AJ; Ferbert A; Alberts MJ; Zivin JA; Wechsler L; Busse O Ann Neurol; 1992 Jul; 32(1):78-86. PubMed ID: 1642475 [TBL] [Abstract][Full Text] [Related]
15. Acute myocardial infarction: is streptokinase really as effective as tissue plasminogen activator? Vine DL Kans Med; 1990 May; 91(5):147-8. PubMed ID: 2115093 [No Abstract] [Full Text] [Related]
16. Intravenous thrombolysis with recombinant staphylokinase versus tissue-type plasminogen activator in a rabbit embolic stroke model. Vanderschueren S; Van Vlaenderen I; Collen D Stroke; 1997 Sep; 28(9):1783-8. PubMed ID: 9303026 [TBL] [Abstract][Full Text] [Related]
17. Alteplase for thrombolysis in acute ischemic stroke. Med Lett Drugs Ther; 1996 Nov; 38(987):99-100. PubMed ID: 8914507 [No Abstract] [Full Text] [Related]
18. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. Wolpert SM; Bruckmann H; Greenlee R; Wechsler L; Pessin MS; del Zoppo GJ AJNR Am J Neuroradiol; 1993; 14(1):3-13. PubMed ID: 8427107 [TBL] [Abstract][Full Text] [Related]
19. Thrombolytic therapy with streptokinase and tissue plasminogen activator in a patient with suspected acute myocardial infarction: A decision analysis. Hiatt MD Cardiology; 1999; 91(4):243-9. PubMed ID: 10545680 [TBL] [Abstract][Full Text] [Related]
20. Direct thrombin inhibition and thrombolytic therapy: rationale for the Hirulog and Early Reperfusion/Occlusion (HERO-2) trial. White HD Am J Cardiol; 1998 Oct; 82(8B):57P-62P. PubMed ID: 9809893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]